No visible difference apparent: not a duplication at either the cytological level or at the DNA level.
Dual phenotype of elevated DDC activity and increased resistance to dietary and methyl dopa relative to Oregon-R derived controls (DdcC). Specific DDC activity of newly eclosed adults 141% and DDC crossreacting material (CRM) 137% of the DdcC control. Interpretation of phenotype identical to that for DdcRE. Specific DDC activity of newly eclosed adult CyO/Ddc heterozygotes, as percentage of CyO/+ control: 141
Coordinately increases the function of Ddc and amd. Mutation is not a duplication.